| Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer | |
| Wang, Cun; Jin, Haojie; Gao, Dongmei; Lieftink, Cor; Evers, Bastiaan; Jin, Guangzhi; Xue, Zheng; Wang, Liqin; Beijersbergen, Roderick L.; Qin, Wenxin | |
| 刊名 | JOURNAL OF HEPATOLOGY
 |
| 2018 | |
| 卷号 | 69期号:5 |
| 关键词 | Hepatocellular carcinoma CRISPR screen Sorafenib MAPK1 |
| ISSN号 | 0168-8278 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3606451 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Wang, Cun,Jin, Haojie,Gao, Dongmei,et al. Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer[J]. JOURNAL OF HEPATOLOGY,2018,69(5). |
| APA | Wang, Cun.,Jin, Haojie.,Gao, Dongmei.,Lieftink, Cor.,Evers, Bastiaan.,...&Bernards, Rene.(2018).Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer.JOURNAL OF HEPATOLOGY,69(5). |
| MLA | Wang, Cun,et al."Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer".JOURNAL OF HEPATOLOGY 69.5(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论